Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Adalimumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Adalimumabmarket, defines the market attractiveness level of Adalimumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Adalimumab industry, describes the types of Adalimumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Adalimumab market and the development prospects and opportunities of Adalimumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Adalimumab market in Chapter 13.
By Player:
Boehringer Ingelheim
Biogen
Sandoz
Amgen
Mylan
AbbVie
By Type:
Adalimumab
Adalimumab Biosimilar
By End-User:
Adults
Children
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Adalimumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Adalimumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Adalimumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Adalimumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Adalimumab Market Analysis and Outlook to 2022
-
7.1 Global Adalimumab Consumption (2017-2022)
-
7.2 United States Adalimumab Consumption (2017-2022)
-
7.3 Europe Adalimumab Consumption (2017-2022)
-
7.4 China Adalimumab Consumption (2017-2022)
-
7.5 Japan Adalimumab Consumption (2017-2022)
-
7.6 India Adalimumab Consumption (2017-2022)
-
7.7 South Korea Adalimumab Consumption (2017-2022)
8 Region and Country-wise Adalimumab Market Analysis and Outlook to 2028
-
8.1 Global Adalimumab Consumption Forecast (2022-2028)
-
8.2 United States Adalimumab Consumption Forecast (2022-2028)
-
8.3 Europe Adalimumab Consumption Forecast (2022-2028)
-
8.4 China Adalimumab Consumption Forecast (2022-2028)
-
8.5 Japan Adalimumab Consumption Forecast (2022-2028)
-
8.6 India Adalimumab Consumption Forecast (2022-2028)
-
8.7 South Korea Adalimumab Consumption Forecast (2022-2028)
9 Global Adalimumab Market Outlook by Types and Applications to 2022
-
9.1 Global Adalimumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adalimumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Adalimumab Biosimilar Consumption and Growth Rate (2017-2022)
-
9.2 Global Adalimumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Children Consumption and Growth Rate (2017-2022)
10 Global Adalimumab Market Outlook by Types and Applications to 2028
-
10.1 Global Adalimumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Adalimumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Adalimumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)
11 Global Adalimumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Adalimumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Adalimumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Adalimumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Adalimumab Market Competitive Analysis
-
14.1 Boehringer Ingelheim
-
14.1.1 Boehringer Ingelheim Company Details
-
14.1.2 Boehringer Ingelheim Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Boehringer Ingelheim Adalimumab Product and Service
-
14.2 Biogen
-
14.2.1 Biogen Company Details
-
14.2.2 Biogen Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biogen Adalimumab Product and Service
-
14.3 Sandoz
-
14.3.1 Sandoz Company Details
-
14.3.2 Sandoz Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sandoz Adalimumab Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Adalimumab Product and Service
-
14.5 Mylan
-
14.5.1 Mylan Company Details
-
14.5.2 Mylan Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mylan Adalimumab Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Adalimumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Adalimumab
-
Figure Adalimumab Picture
-
Table Global Adalimumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Adalimumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Adalimumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Adalimumab Consumption by Country (2017-2022)
-
Figure United States Adalimumab Consumption and Growth Rate (2017-2022)
-
Table Europe Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure China Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure India Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Adalimumab Consumption Forecast by Country (2022-2028)
-
Figure United States Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Adalimumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adalimumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Adalimumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Adalimumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Adalimumab Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Adalimumab Product and Service
-
Table Sandoz (Foundation Year, Company Profile and etc.)
-
Table Sandoz Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Adalimumab Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Adalimumab Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Adalimumab Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Adalimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Adalimumab Product and Service
-
